Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 4351-4400 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT06235775
Administration of GV1001 for the Treatment of Progressive Supranuclear Palsy Who Completed Study GV1001-PSP-CL2-011
PHASE2
Active, not recruiting
67 participants
Started: Dec 12, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
5 locations
NCT06338605
Evaluating the Incidence of Pseudo-Acute Kidney Injuries in Patients With Metastatic Breast Cancer on CDK4/6 Inhibitors Trough Cystatin C Analysis
N/A
Active, not recruiting
40 participants
Started: Dec 12, 2023 · Completed: Jun 1, 2024
1 condition
1 sponsor
1 location
NCT06152237
Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study)
PHASE1/PHASE2
Active, not recruiting
6 participants
Started: Dec 12, 2023 · Completed: Nov 2, 2031
1 condition
1 sponsor
5 locations
NCT06091254
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Follicular Lymphoma
PHASE3
Active, not recruiting
462 participants
Started: Dec 12, 2023 · Completed: Nov 6, 2031
1 condition
1 sponsor
187 locations
NCT06149403
A Study to Investigate the Efficacy and Safety of OTL-203 in Subjects With MPS-IH Compared With Standard of Care With Allogeneic HSCT
PHASE3
Active, not recruiting
41 participants
Started: Dec 11, 2023 · Completed: Mar 31, 2031
1 condition
1 sponsor
5 locations
NCT06144840
INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP
PHASE3
Active, not recruiting
165 participants
Started: Dec 11, 2023 · Completed: Jun 30, 2026
2 conditions
1 sponsor
36 locations
NCT05510687
Transforming Households With Refraction and Innovative Financial Technology
NA
Active, not recruiting
571 participants
Started: Dec 10, 2023 · Completed: Dec 31, 2025
1 condition
8 sponsors
1 location
NCT06093113
Alba - a Mobile App to Provide Bereavement Support for Adolescents in Grief
NA
Active, not recruiting
126 participants
Started: Dec 10, 2023 · Completed: Nov 1, 2026
1 condition
1 sponsor
1 location
NCT07052006
HT-6184 in Subjects With MDS
PHASE2
Active, not recruiting
37 participants
Started: Dec 9, 2023 · Completed: Mar 31, 2026
2 conditions
1 sponsor
10 locations
NCT06234488
Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study
N/A
Active, not recruiting
125 participants
Started: Dec 8, 2023 · Completed: Dec 30, 2025
7 conditions
1 sponsor
22 locations
NCT06162585
Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study
N/A
Active, not recruiting
18 participants
Started: Dec 8, 2023 · Completed: Sep 30, 2027
7 conditions
1 sponsor
6 locations
NCT05966662
Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)
NA
Active, not recruiting
145 participants
Started: Dec 8, 2023 · Completed: Jan 31, 2026
2 conditions
1 sponsor
18 locations
NCT06370650
Effect of Platelet Rich Plasma on Outcome of Narrow Band UVB in Treatment of Vitiligo; Clinical and Histopathological Study
NA
Active, not recruiting
30 participants
Started: Dec 8, 2023 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT06482840
Safety and Efficacy of EasyCool Catheter
N/A
Active, not recruiting
15 participants
Started: Dec 8, 2023 · Completed: Aug 31, 2024
1 condition
1 sponsor
1 location
NCT04875429
Zenith® Fenestrated+ Clinical Study
NA
Active, not recruiting
102 participants
Started: Dec 8, 2023 · Completed: Aug 31, 2031
4 conditions
1 sponsor
32 locations
NCT06253377
Continuous Renal Replacement Therapy With Oxiris in Acute Kidney Injury and Sepsis
N/A
Active, not recruiting
50 participants
Started: Dec 8, 2023 · Completed: Apr 30, 2025
2 conditions
2 sponsors
1 location
NCT06252207
Desflurane Versus Isoflurane for Speeding Postanesthetic Recovery and Hospital Discharge
NA
Active, not recruiting
2,619 participants
Started: Dec 8, 2023 · Completed: Dec 1, 2026
1 condition
1 sponsor
1 location
NCT05548023
Time-trend Analysis of Clinical Characteristic and Outcomes in Patients With Unprotected Left Main Coronary Artery Disease Treated With PCI Over a 10-year Period
NA
Active, not recruiting
500 participants
Started: Dec 8, 2023 · Completed: Feb 7, 2025
1 condition
1 sponsor
1 location
NCT06087133
Prenatal Starting Early Program mHealth
NA
Active, not recruiting
276 participants
Started: Dec 8, 2023 · Completed: Apr 14, 2026
1 condition
2 sponsors
1 location
NCT06026046
Feasibility of an Adapted Sports Program Based on Fencing to Reduce Physical Deconditioning in Adult Hematology Patients
NA
Active, not recruiting
80 participants
Started: Dec 7, 2023 · Completed: Jun 13, 2026
2 conditions
1 sponsor
2 locations
NCT06446024
Post Market Surveillance to Evaluate the Efficacy and Safety of the INDIGO Aspiration System in Japan
N/A
Active, not recruiting
500 participants
Started: Dec 7, 2023 · Completed: Aug 31, 2025
3 conditions
1 sponsor
1 location
NCT05586308
Incentive-based and Media Literacy Informed Approaches to Improve Vaping Cessation
NA
Active, not recruiting
80 participants
Started: Dec 7, 2023 · Completed: Jun 30, 2025
8 conditions
2 sponsors
1 location
NCT06143839
VYxeoS Liposomal Italian Observational Study iN the Real Practice
N/A
Active, not recruiting
112 participants
Started: Dec 7, 2023 · Completed: Feb 1, 2026
3 conditions
2 sponsors
24 locations
NCT06144632
A Study of the THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic PAF
NA
Active, not recruiting
237 participants
Started: Dec 7, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
29 locations
NCT06181136
Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A)
PHASE1/PHASE2
Active, not recruiting
20 participants
Started: Dec 7, 2023 · Completed: Aug 31, 2028
1 condition
1 sponsor
4 locations
NCT05798663
Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC
PHASE2
Active, not recruiting
178 participants
Started: Dec 7, 2023 · Completed: Nov 30, 2026
1 condition
2 sponsors
15 locations
NCT06150014
A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B
PHASE1/PHASE2
Active, not recruiting
88 participants
Started: Dec 7, 2023 · Completed: Sep 30, 2026
1 condition
1 sponsor
3 locations
NCT05722327
Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer
PHASE1
Active, not recruiting
24 participants
Started: Dec 6, 2023 · Completed: Sep 30, 2027
2 conditions
2 sponsors
1 location
NCT05836584
Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer
PHASE2
Active, not recruiting
240 participants
Started: Dec 6, 2023 · Completed: Oct 31, 2027
10 conditions
1 sponsor
133 locations
NCT06187779
Induction ATAD Catheter and Lower Segment Thickness
NA
Active, not recruiting
500 participants
Started: Dec 6, 2023 · Completed: Dec 6, 2026
1 condition
1 sponsor
1 location
NCT06141850
Promoting Engagement and COVID-19 Testing for Health
NA
Active, not recruiting
284 participants
Started: Dec 6, 2023 · Completed: Aug 31, 2025
1 condition
4 sponsors
1 location
NCT05994625
Economic Evaluation of Stream™ Platform
PHASE3
Active, not recruiting
215 participants
Started: Dec 6, 2023 · Completed: Jun 30, 2026
1 condition
3 sponsors
2 locations
NCT06132958
Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)
PHASE3
Active, not recruiting
710 participants
Started: Dec 6, 2023 · Completed: Jan 10, 2028
1 condition
3 sponsors
242 locations
NCT06056024
A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus
PHASE1
Active, not recruiting
47 participants
Started: Dec 6, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
17 locations
NCT05964361
First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients
PHASE1/PHASE2
Active, not recruiting
10 participants
Started: Dec 6, 2023 · Completed: Sep 28, 2025
4 conditions
3 sponsors
1 location
NCT06056050
A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)
PHASE1
Active, not recruiting
180 participants
Started: Dec 6, 2023 · Completed: Sep 28, 2025
3 conditions
1 sponsor
1 location
NCT06256328
A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)
PHASE2
Active, not recruiting
210 participants
Started: Dec 6, 2023 · Completed: Jul 31, 2027
1 condition
1 sponsor
63 locations
NCT06532331
A PhaseⅠStudy of ONO-7475 in Combination With ONO-4538 and Gemcitabine Plus Nab-paclitaxel (GnP), the Standard of Care, and ONO-7475 in Combination With GnP in Patients With Pancreatic Cancer
PHASE1
Active, not recruiting
87 participants
Started: Dec 6, 2023 · Completed: Mar 31, 2028
1 condition
1 sponsor
9 locations
NCT06127420
Comprehensive Assessment on Diagnostic and Prognostic Performance of Coronary Physiological Indices
N/A
Active, not recruiting
3,000 participants
Started: Dec 6, 2023 · Completed: Nov 30, 2024
1 condition
1 sponsor
1 location
NCT04870125
Safety Study of Inhaled Carbon Monoxide to Treat Pneumonia and Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)
PHASE1
Active, not recruiting
5 participants
Started: Dec 6, 2023 · Completed: Oct 31, 2025
2 conditions
6 sponsors
6 locations
NCT06258746
Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK31679 in Healthy Adult Male Volunteers.
PHASE1
Active, not recruiting
6 participants
Started: Dec 5, 2023 · Completed: Dec 30, 2024
1 condition
1 sponsor
1 location
NCT06426641
Polyethylene Wear Particle Analysis of TKA
N/A
Active, not recruiting
90 participants
Started: Dec 5, 2023 · Completed: Dec 31, 2028
2 conditions
4 sponsors
2 locations
NCT05997264
Anthrax AV7909 Boost Evaluation Study
PHASE2
Active, not recruiting
220 participants
Started: Dec 5, 2023 · Completed: Aug 31, 2026
1 condition
3 sponsors
7 locations
NCT06187766
Effects of Social Media Addiction on Physical Activity Level and Exercise Capacity in University Students
N/A
Active, not recruiting
110 participants
Started: Dec 5, 2023 · Completed: Dec 20, 2024
3 conditions
1 sponsor
1 location
NCT06187194
Efficacy and Safety of Irreversible Electroporation for Chronic Symptomatic Tonsillar Hypertrophy Treatment
NA
Active, not recruiting
40 participants
Started: Dec 5, 2023 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT05911321
Isa-Pom-Dex in Elderly/Frail Subjects With RRMM
PHASE2
Active, not recruiting
6 participants
Started: Dec 5, 2023 · Completed: Mar 26, 2028
5 conditions
2 sponsors
2 locations
NCT06139328
IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack
PHASE2
Active, not recruiting
160 participants
Started: Dec 5, 2023 · Completed: Dec 3, 2026
1 condition
1 sponsor
50 locations
NCT05908786
A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma
PHASE1/PHASE2
Active, not recruiting
62 participants
Started: Dec 5, 2023 · Completed: Sep 30, 2028
1 condition
1 sponsor
33 locations
NCT06127524
Skin Change Actions by Nursing
PHASE2
Active, not recruiting
4,733 participants
Started: Dec 4, 2023 · Completed: Jun 30, 2026
1 condition
5 sponsors
7 locations
NCT06210503
PENG Block in Comparison With FICB for Hip Reconstruction in Children
NA
Active, not recruiting
86 participants
Started: Dec 4, 2023 · Completed: Nov 1, 2025
2 conditions
1 sponsor
1 location
Previous
1
More pages
85
86
87
88
89
90
91
More pages
431
Next